Delivery Order SPE2DE24D0013-SPE2D625F3QMR
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,097.20 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 2, 2025, with an ultimate completion date of May 16, 2025. This firm fixed-price delivery order, designated GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of the federal government's ongoing relationship with Cepheid for diagnostic testing capabilities. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,468.30 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, covers diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award carries no set-aside designation and represents a task order under...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3QMRDelivery Order
The Defense Department's Medical Supply Chain awarded a $2,500 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order (GXMRSA-NXG-10) carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale facility. The award is structured as a delivery order under one of Cepheid's larger Indefinite Delivery Vehicle contracts with the Veterans Integrated Service Network 21, which provides a $2.5 million vehicle for PCR testing and laboratory microbiology services supporting diagnostics for COVID-19, influenza, RSV, C. difficile, women's health infections, and tuberculosis across the VA healthcare system. Cepheid specializes in GeneXpert diagnostic systems and associated molecular reagents, test kits, and maintenance services for infectious disease and clinical testing. The contractor has established a substantial presence in the federal healthcare marketplace, holding multiple prime contracts with the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency. Beyond equipment and services delivery, Cepheid has participated in collaborative research initiatives, including work with Rutgers University on point-of-care detection methods for drug-resistant tuberculosis and procurement support for diagnostic methodologies in international settings, demonstrating the company's comprehensive capabilities across diagnostic technology development and deployment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/16/25 |